Epstein-Barr Virus EA-IgA, VCA-IgA, and EBVNA-IgG Antibodies in a Population of Wuhan, China

Abstract

The study investigated the distribution of Epstein-Barr virus (EBV) EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in a local population of Wuhan, China. Chemiluminescence immunoassay (CLIA) was used to detect EBV EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in 972 subjects undergoing physical examination in Wuhan, and the results were analyzed. The detection rate of EBV was positively correlated with age. In the 972 cases, there was significant difference between different genders in the positive rate of VCA-IgA and EBVNA-IgG. Moreover, the positive rate of VCA-IgA and EBVNA-IgG was higher in men ≥ 60 years old than in those < 60 but no significant differences were found in three antibodies among various age groups. Our results suggested that the EBV infection should be intensively monitored in elderly people in Wuhan.

Keywords

Epstein-Barr virus / nasopharyngeal carcinoma / antibody / physical examination

References

[1] ThompsonMP, KurzrockR. Epstein-Barr virus and cancer. Clin Cancer Res, 2004, 10(3): 803-821

[2] WuZR, LiG, WuL, et al.. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. BMC Cancer, 2009, 315(9): 1-14

[3] WeiWI, ShamJS. Nasopharyngeal carcinoma. Lancet, 2005, 365(9476): 2041-2054

[4] ChengWM, ChanKH, ChenHL, et al.. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer, 2002, 97(4): 489-492

[5] WuWH, ChenGX, WuZB, et al.. Serological detection of EB virus in early detection and screening of nasopharyngeal carcinoma. Cancer, 2006, 25(2): 250-256

[6] PengZX, HuangZY, TangYL, et al.. Application of EB virus antibody detection in nasopharyngeal carcinoma class II prevention. Guangxi Med (Chinese), 1999, 21(4): 611-614

[7] ChenP, XiaoZY. Detection of antibodies to EB virus VCA-IgA in 1367 employees of a university in Fuzhou. J Fujian Med Univ (Chinese), 2006, 40(1): 86-92

[8] DengH, CengY, ZhengYM, et al.. Serological survey of 413 164 nasopharyngeal carcinoma in natural population. Chin Oncol, 2003, 13(2): 109-111

[9] DengH, JingY, ZhengYM, et al.. Serological survey of nasopharyngeal carcinoma in 413 164 natural population. Chin Oncol, 2007, 23(7): 492-493

[10] LiY. Investigation of EB virus VCA/IgA in 16 873 people undergoing physical examination. Wenxuan Med (Chinese), 2005, 24(6): 894-895

[11] SheblFM, BhatiaK, EngelsEA. Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer, 2010, 126: 2503-2508

[12] LiangHT, YeY, ChenL, et al.. Investigation and analysis of EB virus infection among Guangzhou health examination personnel. Cli Med Engineering, 2010, 17(6): 131-132

[13] OkanM. Overview and problematic standpoints of severe chronic Epstein-Barr virus infection syndrome. Oncol Hematol, 2002, 44(4): 273-282

[14] HanTT, XuLP, LiuDH. Analysis of EB virus infection after allogeneic hematopoietic stem cell transplantation. Chin J Hematol (Chinese), 2013, 8(6): 651-654

[15] DraborgAH, DuusK, HouenG. Epstein-Bar virus in systemic autoimmune diseases. Clin Dev Immunol, 2013, 8(1): 1-9

[16] WangPP, JiMF. Research progress in serological screening of nasopharyngeal carcinoma. Tumor Res Bedside, 2013, 8(5): 572-573